Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › N-[3-[2-(1H-imidazol-1-yl)ethoxy]phenyl]-4-(2-thienyl)-2-pyrimidinamine and pharmacologically acceptable salts

N-[3-[2-(1H-imidazol-1-yl)ethoxy]phenyl]-4-(2-thienyl)-2-pyrimidinamine and pharmacologically acceptable salts

US Patent 5162328 · Granted Nov 10, 1992

Estimated economic value: $6,830,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Systems and methods for processing carbonaceous feedstock2024
Systems and methods for processing carbonaceous feedstock2022
Systems and methods for processing carbonaceous feedstock2021
Method of reducing accumulation of intracellular tingible body macrophages2018
Lysosomal phospholipase A2 (LPLA2) activity as a therapeutic target for treating2016
Lysosomal phospholipase A2 (LPLA2) activity as a diagnostic and therapeutic targ2011
Integrated systems with electroluminescent illumination and methods thereof2007
Embeddable corrosion monitoring-instrument for steel reinforced structures2004
MDR reversal agents1997
MDR reversal agents1996
Composite abrasive products1996
MDR reversal agents1996